1. Home
  2. RGNX vs BIT Comparison

RGNX vs BIT Comparison

Compare RGNX & BIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • BIT
  • Stock Information
  • Founded
  • RGNX 2008
  • BIT 2013
  • Country
  • RGNX United States
  • BIT United States
  • Employees
  • RGNX N/A
  • BIT N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • BIT Trusts Except Educational Religious and Charitable
  • Sector
  • RGNX Health Care
  • BIT Finance
  • Exchange
  • RGNX Nasdaq
  • BIT Nasdaq
  • Market Cap
  • RGNX 661.2M
  • BIT 573.0M
  • IPO Year
  • RGNX 2015
  • BIT N/A
  • Fundamental
  • Price
  • RGNX $11.86
  • BIT $13.02
  • Analyst Decision
  • RGNX Strong Buy
  • BIT
  • Analyst Count
  • RGNX 7
  • BIT 0
  • Target Price
  • RGNX $30.29
  • BIT N/A
  • AVG Volume (30 Days)
  • RGNX 537.9K
  • BIT 92.4K
  • Earning Date
  • RGNX 11-06-2025
  • BIT 01-01-0001
  • Dividend Yield
  • RGNX N/A
  • BIT 9.36%
  • EPS Growth
  • RGNX N/A
  • BIT N/A
  • EPS
  • RGNX N/A
  • BIT N/A
  • Revenue
  • RGNX $161,318,000.00
  • BIT N/A
  • Revenue This Year
  • RGNX $198.02
  • BIT N/A
  • Revenue Next Year
  • RGNX $2.67
  • BIT N/A
  • P/E Ratio
  • RGNX N/A
  • BIT N/A
  • Revenue Growth
  • RGNX 91.30
  • BIT N/A
  • 52 Week Low
  • RGNX $5.04
  • BIT $13.65
  • 52 Week High
  • RGNX $13.93
  • BIT $15.97
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 53.04
  • BIT 38.31
  • Support Level
  • RGNX $10.70
  • BIT $12.90
  • Resistance Level
  • RGNX $12.05
  • BIT $13.37
  • Average True Range (ATR)
  • RGNX 0.73
  • BIT 0.10
  • MACD
  • RGNX -0.10
  • BIT -0.02
  • Stochastic Oscillator
  • RGNX 79.32
  • BIT 25.26

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About BIT BlackRock Multi-Sector Income Trust of Beneficial Interest

BlackRock Multi-Sector Income Trust is a closed-end investment management company. It invests on behalf of its clients. The fund's primary investment objective is to provide a high level of current income, with a secondary objective of capital appreciation. The company seeks to achieve its investment objectives by investing, under normal market conditions, a majority of its assets in loan and debt instruments and other investments with similar economic characteristics. Its portfolio consists of Corporate Bonds, Asset-Backed Securities, Preferred Securities, and others.

Share on Social Networks: